Genome Editing and Cardiac Arrhythmias

Area of Science:

• Cardiovascular Medicine
• Genetics
• Molecular Biology

Background:

• Cardiac arrhythmias represent a significant health burden.
• Inherited arrhythmia syndromes often stem from specific genetic defects.
• Current treatments for arrhythmias have limitations.

Purpose of the Study:

• To review the progress and potential of cardiac genome editing for treating arrhythmias.
• To discuss genome editing techniques applicable to cardiomyocytes.
• To explore in vivo applications and gene transfer advancements.

Main Methods:

• Review of genome editing technologies (e.g., CRISPR-Cas9) for DNA modification.
• Analysis of preclinical studies using in vivo genome editing in arrhythmia models.
• Examination of cardiac gene transfer methods and optimization strategies.

Main Results:

• Genome editing can disrupt, insert, delete, or correct DNA in cardiomyocytes.
• In vivo genome editing has shown potential in preclinical models of arrhythmias.
• Advancements in cardiac gene transfer include improved delivery and expression control.

Conclusions:

• Cardiac genome editing is an emerging therapeutic strategy for arrhythmias.
• The approach holds particular promise for inherited arrhythmia syndromes.
• Further research is needed to address delivery and safety for therapeutic somatic genome editing.